Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Br J Haematol
    September 2025
  1. CHANG M, Semakula D, Little JA, Kanter J, et al
    Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.
    Br J Haematol. 2025;207:1070-1075.
    >> Share

  2. SHANGGUAN S, Cui X, Li J, Li N, et al
    Alu-mediated FANCD2 exonic deletion contributes to Fanconi anaemia.
    Br J Haematol. 2025;207:1076-1084.
    >> Share

  3. CHAMBLISS C, Manci E, Fields E, Bueno J, et al
    Characterizing pregnancy outcomes in a humanized mouse model of sickle cell disease.
    Br J Haematol. 2025;207:813-823.
    >> Share

  4. HAJJAJ OI, Callum J, Shehata N, Farrell A, et al
    Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review.
    Br J Haematol. 2025;207:723-736.
    >> Share

  5. LEUNG WY, Lee TY, Hwang YY, Lee JT, et al
    Iron overload and morbidities in Chinese with non-transfusion-dependent thalassaemia.
    Br J Haematol. 2025;207:1058-1069.
    >> Share

    August 2025
  6. ZHANG L, Liu Z, Zhao X, Hu B, et al
    Efficacy and safety of HRS-5965 monotherapy in complement inhibitor-naive patients with paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2025;207:571-581.
    >> Share

  7. TEAWTRAKUL N, Jetsrisuparb A, Pongudom S, Chansung K, et al
    Survival and thalassaemia-related complications in HbE/beta-thalassaemia and alpha-thalassaemia: A 10-year longitudinal study in Thailand.
    Br J Haematol. 2025;207:552-560.
    >> Share

  8. LEE JW, Jang JH, Chiba S, Yoon SS, et al
    Romiplostim with ciclosporin A in patients with aplastic anaemia naive to immunosuppressive therapy: A phase 2/3 study.
    Br J Haematol. 2025;207:582-590.
    >> Share

  9. AFZALI-HASHEMI L, Franse M, Baas KPA, Schrantee A, et al
    Assessment of neurocognitive functioning in sickle cell disease and thalassaemia and the association with silent cerebral infarcts, cerebral haemodynamics and oxygen metabolism.
    Br J Haematol. 2025;207:561-570.
    >> Share

    July 2025
  10. LOH J, Kuo KHM, Georgescu I, Wang S, et al
    Risk factors for immediate postpartum sickle cell disease-specific maternal morbidity.
    Br J Haematol. 2025;207:225-234.
    >> Share

  11. WILSON SR, Noubouossie D, Little JA, Karafin MS, et al
    Real-world assessment of acute red cell exchange for stroke in sickle cell disease.
    Br J Haematol. 2025;207:217-224.
    >> Share

  12. DIAW M, Coly MS, Charlot K, Gallou-Guyot M, et al
    Physical activity, vaso-occlusive crises and pain in patients with sickle cell anaemia in Senegal.
    Br J Haematol. 2025;207:206-216.
    >> Share

  13. SANTINI V, Consagra A
    How to use luspatercept and erythropoiesis-stimulating agents in low-risk myelodysplastic syndrome.
    Br J Haematol. 2025;207:15-26.
    >> Share

    June 2025
  14. KUO KHM, Layton DM, Lal A, Vichinsky EP, et al
    Long-term efficacy and safety of mitapivat in non-transfusion-dependent alpha- or beta-thalassaemia: An open-label phase 2 study.
    Br J Haematol. 2025;206:1764-1773.
    >> Share

  15. VISTICA SAMPINO E, Bonal DM, Chorzalska A, Morgan J, et al
    Alterations in the humoral immunophenotype in sickle cell disease.
    Br J Haematol. 2025;206:1774-1785.
    >> Share

  16. RICCHI P
    The double edge of erythropoietic modulation in thalassaemia.
    Br J Haematol. 2025;206:1879-1880.
    >> Share

  17. HARJU T, Raiskila S, Lohi O, Jarvela L, et al
    Increased incidence of autoimmune haemolytic anaemia with paroxysmal cold haemoglobinuria features in paediatric cases in a changing viral environment post-COVID-19 pandemic.
    Br J Haematol. 2025;206:1872-1876.
    >> Share

  18. PALANI CD, Smith A, Cao X, Li B, et al
    Cholesterol-conjugated miR-29b induces fetal haemoglobin expression via gamma-globin promoter demethylation in the Townes mouse model for sickle cell anaemia.
    Br J Haematol. 2025;206:1786-1795.
    >> Share

  19. ZAIDEL B, Garland S, Merkeley H
    Acute splenomegaly, haemolysis, and thrombocytopenia following luspatercept initiation in a patient with transfusion-dependent thalassaemia: A case report.
    Br J Haematol. 2025;206:1806-1810.
    >> Share

  20. BRANDSEN RP, Diederen RMH, Klaassen I, Veldthuis M, et al
    The role of red blood cell characteristics and viscosity in sickle cell retinopathy and maculopathy.
    Br J Haematol. 2025;206:1796-1805.
    >> Share

  21. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
    Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasms.
    Br J Haematol. 2025;206:1689-1698.
    >> Share

  22. JACOBS JW, Amorim L, Pirenne F, Tayou C, et al
    The wider perspective: Barriers and recommendations for transfusion support for patients with sickle cell disease in low- and middle-income countries.
    Br J Haematol. 2025;206:1585-1592.
    >> Share

  23. BALCIUNIENE J, Yilmaz S, Chonat S, Grace RF, et al
    Real-world insights from a cohort of approximately 2000 individuals who were analysed using a freely available next-generation sequencing anaemia screening programme.
    Br J Haematol. 2025;206:1853-1856.
    >> Share

    May 2025
  24. MACLEAN B, Fuller J, Lim J, Dugan C, et al
    Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia.
    Br J Haematol. 2025;206:1479-1484.
    >> Share

  25. DELICOU S, Manganas K, Diamantidis MD, Venou TM, et al
    Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12-year study.
    Br J Haematol. 2025;206:1466-1478.
    >> Share

  26. PRINCE EJ, Scott JL, Nwankwoala O, Ali-Houchens L, et al
    A young adult clinic to support integration into adult sickle cell disease care: If you build it, they will come.
    Br J Haematol. 2025;206:1458-1465.
    >> Share

    April 2025
  27. HOVING V, Donker AE, Schols SEM, Swinkels DW, et al
    How I treat iron-refractory iron deficiency anaemia-An expert opinion-based treatment guidance for children and adults.
    Br J Haematol. 2025;206:1067-1076.
    >> Share

  28. METAFUNI E, Brioschi FA, Patriarca A, Leoni C, et al
    Real-world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study.
    Br J Haematol. 2025;206:1246-1249.
    >> Share

  29. CORSIA A, Joseph L, Beeker N, Manceau S, et al
    Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.
    Br J Haematol. 2025;206:1218-1227.
    >> Share

  30. ENACHE A, Carty SA, Babushok DV
    Origins of T-cell-mediated autoimmunity in acquired aplastic anaemia.
    Br J Haematol. 2025;206:1035-1053.
    >> Share

  31. SINHA U, Setty S, Pilon C, Brown JJ, et al
    Systemic lupus erythematosus-associated autoantibodies in sickle cell disease: Spontaneous emergence in a patient and in transgenic sickle mice.
    Br J Haematol. 2025;206:1213-1217.
    >> Share

    March 2025
  32. DE LIGT LA, Gaartman AE, Konte K, Thakoerdin S, et al
    Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease.
    Br J Haematol. 2025;206:954-964.
    >> Share

  33. SCHECHTER AN
    Sickle cell anaemia therapy in 2025.
    Br J Haematol. 2025;206:842-845.
    >> Share

  34. LONGORIA JN, Howell KE, Porter JS, Treadwell M, et al
    Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation Consortium.
    Br J Haematol. 2025;206:944-953.
    >> Share

  35. LI H, Sachdev V, Tian X, Nguyen ML, et al
    A machine learning-based workflow for predicting transplant outcomes in patients with sickle cell disease.
    Br J Haematol. 2025;206:919-923.
    >> Share

    February 2025
  36. MAGGIO A, Napolitano M, Taher AT, Bou-Fakhredin R, et al
    Reframing thalassaemia syndrome as a benign haematopoietic stem cell disorder.
    Br J Haematol. 2025;206:464-477.
    >> Share

  37. ZHANG J, Sun J, Huai W, Tang J, et al
    Elucidating loss-of-function mechanisms of monoallelic EPAS1 mutations underlying congenital hypoplastic anaemia in a paediatric anaemia cohort.
    Br J Haematol. 2025;206:585-595.
    >> Share

  38. EL HOSS S, Bazoum H
    From old to new: Repurposed drugs in the battle towards curing sickle cell disease.
    Br J Haematol. 2025;206:795-797.
    >> Share

  39. BHAT V, Potdar AA, Yu GK, Gibson G, et al
    Impact of hydroxycarbamide treatment on the whole-blood transcriptome in sickle cell disease.
    Br J Haematol. 2025;206:713-720.
    >> Share

  40. GURNARI C, Visconte V
    Dissecting the genomic traits and clinical course of secondary myelodysplastic syndrome following aplastic anaemia: A milestone.
    Br J Haematol. 2025;206:790-791.
    >> Share

  41. QI J, Wang T, Wang M, He P, et al
    Comparative study of the diversity of amino acids on human leucocyte antigen class II molecules in patients with acquired aplastic anaemia.
    Br J Haematol. 2025;206:735-748.
    >> Share

  42. RAZ S, Koren A, Bogdanova AY, Gassmann M, et al
    Memantine treatment in sickle cell disease: A 1-year study of its effects on cognitive functions and neural processing.
    Br J Haematol. 2025;206:689-702.
    >> Share

  43. SONGDEJ D, Teawtrakul N, Laoaroon N, Komvilaisak P, et al
    Impact of HbE mutation on the clinical severity of HbH disease: A multicentre study from Thailand.
    Br J Haematol. 2025;206:703-712.
    >> Share

    January 2025
  44. GE S, Ali S, Haldane V, Bekdache C, et al
    An approach to Hemequity: Identifying the barriers and facilitators of iron deficiency reduction strategies in low- to middle-income countries.
    Br J Haematol. 2025 Jan 6. doi: 10.1111/bjh.19984.
    >> Share

  45. KHAN AA, Laas CE, Brewin JN, Potter V, et al
    Development of a novel test of splenic function for use in a clinical diagnostic laboratory.
    Br J Haematol. 2025;206:320-330.
    >> Share

  46. GEHRIE EA, Booth GS
    Contextualizing prophylactic red blood cell antigen matching in the lifelong care of sickle cell disease and thalassaemia patients.
    Br J Haematol. 2025;206:382-384.
    >> Share

  47. GALADANCI NA, Kanter J
    Avascular necrosis in sickle cell disease needs more definitive treatment options.
    Br J Haematol. 2025;206:385-386.
    >> Share

  48. PIECHNIK SK, Polzella P, Shah A, Vera-Aviles M, et al
    Myocardial iron intake following intravenous iron therapy with ferric carboxymaltose is sustained at 1 year despite recurrence of iron deficiency.
    Br J Haematol. 2025;206:349-352.
    >> Share

  49. NOGUER M, Berthon P, Makowski C, Messonnier LA, et al
    Impaired physical ability in patients with transfusion-dependent beta-thalassaemia: Can regular physical activity be a countermeasure?
    Br J Haematol. 2025;206:86-93.
    >> Share

  50. WOLF J, Blais-Normandin I, Bathla A, Keshavarz H, et al
    Red cell specifications for blood group matching in patients with haemoglobinopathies: An updated systematic review and clinical practice guideline from the International Collaboration for Transfusion Medicine Guidelines.
    Br J Haematol. 2025;206:94-108.
    >> Share

  51. KOCHHAR M, McGann PT
    Sickle cell disease in India: Not just a mild condition.
    Br J Haematol. 2025;206:380-381.
    >> Share

  52. SETH T, Udupi S, Jain S, Bhatwadekar S, et al
    Burden of vaso-occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients.
    Br J Haematol. 2025;206:296-309.
    >> Share

  53. CASALE M, Toro G, Porcelli F, Quota A, et al
    Long-term outcomes of avascular necrosis in sickle cell disease using joint-specific patient-reported outcome measures: Results from a multicentre study.
    Br J Haematol. 2025;206:310-319.
    >> Share

    December 2024
  54. LOTH G, Dumke CCK, Muratori RR, Pelegrina PD, et al
    Haematopoietic cell transplantation for 106 infants and preschoolers with acquired and inherited bone marrow failures.
    Br J Haematol. 2024;205:2387-2402.
    >> Share

  55. SEGBEFIA CI, Smart LR, Stuber SE, Amissah-Arthur KN, et al
    Baseline characteristics of Ghanaian children and adults enrolled in PIVOT, a randomised clinical trial of hydroxyurea in HbSC disease in sub-Saharan Africa.
    Br J Haematol. 2024;205:2470-2480.
    >> Share

    November 2024
  56. COSTA S, Minucci A, Kumawat A, De Bonis M, et al
    Pathogenic G6PD variants: Different clinical pictures arise from different missense mutations in the same codon.
    Br J Haematol. 2024;205:1985-1994.
    >> Share

  57. CINTHO OZAHATA M, Guo Y, Gomes I, Malta B, et al
    Genetic variants associated with white blood cell count amongst individuals with sickle cell disease.
    Br J Haematol. 2024;205:1974-1984.
    >> Share

  58. ELSHERIF L, Tang Y, Patillo KL, Wichlan D, et al
    Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia.
    Br J Haematol. 2024;205:1963-1973.
    >> Share

  59. GURNARI C, Lima ACM, Pagliuca S
    HLA-lacking clones in aplastic anaemia: Adaptive or maladaptive?
    Br J Haematol. 2024;205:1681-1682.
    >> Share

  60. MARIN V, Huguenin Y, Bessi L, Weinmann L, et al
    Beta-thalassaemia intermedia due to a complex alpha-globin rearrangement and a heterozygous beta thalassaemia mutation.
    Br J Haematol. 2024;205:1959-1962.
    >> Share

  61. ZAIMOKU Y, Sakai K, Tsuji N, Hosomichi K, et al
    Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment.
    Br J Haematol. 2024;205:1995-1999.
    >> Share

    October 2024
  62. GUPTA CL, Jaganathasamy N, Madkaikar M
    Microbiome in sickle cell disease: Pathophysiology and therapeutic insights.
    Br J Haematol. 2024;205:1279-1287.
    >> Share

  63. GILTON M, Fernandes H, Martinez C, Leverger G, et al
    Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.
    Br J Haematol. 2024;205:1508-1515.
    >> Share

  64. VALENTINI CG, Teofili L, Gehrie E
    Iron metabolism in sickle cell disease patients undergoing chronic red blood cell exchange: A delicate homeostasis in balance.
    Br J Haematol. 2024;205:1257-1259.
    >> Share

  65. CONNES P, Nader E
    Could oxygen gradient ektacytometry help to detect sickle cell trait carriers at risk for kidney disorders or exercise-related complications?
    Br J Haematol. 2024;205:1260-1261.
    >> Share

  66. RAMSAY Z, Ali A, Grant J, Asnani M, et al
    Exploring the role of viscosity-vaso-occlusion and haemolysis-endothelial dysfunction in pain sensitization among Jamaicans with sickle cell disease.
    Br J Haematol. 2024;205:1570-1580.
    >> Share

  67. M ROSS J, Forte S, Mercure-Corriveau N, Lemay AS, et al
    Automated red blood cell exchange with a post-procedure haematocrit targeted at 34% in the chronic management of sickle cell disease.
    Br J Haematol. 2024;205:1556-1564.
    >> Share

  68. ELLSWORTH P, Pawlinski IJ, Sielaty R, Ilich A, et al
    Hypertonicity and/or acidosis induce marked rheological changes under hypoxic conditions in sickle trait red blood cells.
    Br J Haematol. 2024;205:1565-1569.
    >> Share

  69. KATO S, Chagi K, Takagi Y, Hidaka M, et al
    Machine/deep learning-assisted hemoglobin level prediction using palpebral conjunctival images.
    Br J Haematol. 2024;205:1590-1598.
    >> Share

  70. LEE JM, Kim HS, Yoo J, Lee J, et al
    Genomic insights into inherited bone marrow failure syndromes in a Korean population.
    Br J Haematol. 2024;205:1581-1589.
    >> Share

    September 2024
  71. CATELLA J, Turpin E, Connes P, Nader E, et al
    Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing.
    Br J Haematol. 2024 Sep 24. doi: 10.1111/bjh.19785.
    >> Share

  72. STRAUSS JD, Brown DW, Zhou W, Dagnall C, et al
    Telomere length and clonal chromosomal alterations in peripheral blood of patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1180-1187.
    >> Share

  73. PRABAHRAN A, Durrani J, Coelho-Da Silva J, Shalhoub R, et al
    Safety and efficacy of immunosuppressive therapy for elderly patients with severe aplastic anaemia.
    Br J Haematol. 2024;205:1170-1179.
    >> Share

  74. ZHOU LY, Derebail VK, Desai PC, Elsherif L, et al
    Persistent albuminuria and chronic kidney disease in adults with sickle cell anaemia: Results from a multicenter natural history study.
    Br J Haematol. 2024;205:1159-1169.
    >> Share

  75. SADAF A, Dong M, Pfeiffer A, Korpik J, et al
    A pharmacokinetic-pharmacodynamic analysis of l-glutamine for the treatment of sickle cell disease: Implications for understanding the mechanism of action and evaluating response to therapy.
    Br J Haematol. 2024;205:1147-1158.
    >> Share

  76. NKOY AB, Mumaka FM, Ngonde A, Mafumba SK, et al
    Relevance of repeated analyses of albuminuria and glomerular filtration rate in African children with sickle cell anaemia.
    Br J Haematol. 2024;205:1137-1146.
    >> Share

  77. ZHOU X, Wagner V, Scheller L, Stanojkovska E, et al
    Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.
    Br J Haematol. 2024;205:999-1010.
    >> Share

    August 2024
  78. GLENTHOJ A, Grace RF, Lander C, van Beers EJ, et al
    Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry.
    Br J Haematol. 2024;205:613-623.
    >> Share

  79. KATZ BZ, Karny S
    Pursuing the elusive footsteps of malaria in peripheral blood smears utilizing artificial intelligence.
    Br J Haematol. 2024;205:414-415.
    >> Share

  80. SHARMA A, Kumar A, Rawat K, Vij S, et al
    Novel TMPRSS6 variants and their impact on iron-refractory iron deficiency anaemia in pregnancy: A North Indian genotype phenotype study.
    Br J Haematol. 2024;205:686-698.
    >> Share

  81. RECH JS, Cohen A, Bartolucci P, Santin A, et al
    Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study.
    Br J Haematol. 2024;205:463-472.
    >> Share

  82. SEGBEFIA C, Luchtman-Jones L
    Seeing haemoglobin SC: Challenging the misperceptions.
    Br J Haematol. 2024;205:404-405.
    >> Share

  83. NELSON M, Noisette L, Pugh N, Gordeuk V, et al
    The clinical spectrum of HbSC sickle cell disease-not a benign condition.
    Br J Haematol. 2024;205:653-663.
    >> Share

  84. MOYSIS E, Brown BJ, Shokunbi W, Manescu P, et al
    Leveraging deep learning for detecting red blood cell morphological changes in blood films from children with severe malaria anaemia.
    Br J Haematol. 2024;205:699-710.
    >> Share

  85. SHANDLEY LM, Fasano RM, Spencer JB, Mertens AC, et al
    The impact of sickle cell disease and its treatment on ovarian reserve in reproductive-aged Black women.
    Br J Haematol. 2024;205:674-685.
    >> Share

  86. ROSSI M, Belinga S, Tolo A, Diop S, et al
    Determinants of the haemoglobin level in patients with sickle cell disease living in sub-Saharan Africa: Major impact of the country of residence and independent effects of leucocyte and platelet counts and haemolysis.
    Br J Haematol. 2024;205:664-673.
    >> Share

  87. PIOLATTO A, Gaglioti CM, Tesio N, Clemente MG, et al
    Deferasirox film-coated tablet-associated ulcerative colitis: An emerging pattern in thalassemia patients?
    Br J Haematol. 2024;205:719-721.
    >> Share

  88. HAN J, Zhang X, Shah BN, Saraf SL, et al
    Alkaline phosphatase as a marker for painful vaso-occlusive events and other acute complications in sickle cell disease.
    Br J Haematol. 2024;205:716-718.
    >> Share

    July 2024
  89. CATELLA J, Guillot N, Nader E, Skinner S, et al
    Controversies in the pathophysiology of leg ulcers in sickle cell disease.
    Br J Haematol. 2024;205:61-70.
    >> Share

  90. GOK V, Leblebisatan G, Gurlek Gokcebay D, Guler S, et al
    Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.
    Br J Haematol. 2024;205:236-242.
    >> Share

  91. CHEMINET G, Corbasson A, Charmettan M, Namaoui W, et al
    Assessment of fatigue in adult patients with sickle cell disease: Use of the functional assessment of chronic illness therapy-Fatigue (FACIT-fatigue) questionnaire.
    Br J Haematol. 2024;205:335-342.
    >> Share

  92. MAYRAND L, Elie J, Pinhas Y, Rignault-Bricard R, et al
    Sputum interleukin-6 level as a marker of severity during acute chest syndrome in children with sickle cell disease.
    Br J Haematol. 2024;205:329-334.
    >> Share

  93. PLAZA-FLORIDO A, Liem RI, Haddad F, Radom-Aizik S, et al
    Whole-blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise.
    Br J Haematol. 2024;205:320-328.
    >> Share

  94. ZHANG L, Chang M, Liu C, Xu Y, et al
    A case of de novo -alpha(3.7) thalassaemia and the utility of CATSA for detecting de novo mutations in thalassaemia.
    Br J Haematol. 2024;205:360-363.
    >> Share

  95. PADENIYA P, Premawardhena A
    Obesity, liver steatosis and metabolic syndrome: The hidden enemies in transfusion-dependent thalassaemia.
    Br J Haematol. 2024;205:28-29.
    >> Share

  96. RUIZ MA, Zhang X, Mansilla MA, Zahr RS, et al
    Prevalence of kidney health genetic variants in adults with sickle cell nephropathy.
    Br J Haematol. 2024;205:316-319.
    >> Share

  97. KIM DH, Hong J, Shin DY, Kim I, et al
    Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome.
    Br J Haematol. 2024;205:356-359.
    >> Share

  98. HANDS K, Daru J, Evans C, Kotze A, et al
    Identification and management of preoperative anaemia in adults: A British Society for Haematology Guideline update.
    Br J Haematol. 2024;205:88-99.
    >> Share

    June 2024
  99. GUARNERA L, Visconte V
    The metabolic fuel of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2024;204:2162-2164.
    >> Share

  100. SHAH FT, Nicolle S, Garg M, Pancham S, et al
    Guideline for the management of conception and pregnancy in thalassaemia syndromes: A British Society for Haematology Guideline.
    Br J Haematol. 2024;204:2194-2209.
    >> Share

  101. RICCHI P, Pistoia L, Positano V, Spasiano A, et al
    Liver steatosis in patients with transfusion-dependent thalassaemia.
    Br J Haematol. 2024;204:2458-2467.
    >> Share

  102. ZACCHEDDU E, Zappu A, Barella S, Clemente MG, et al
    Unplanned pregnancy in women with beta-thalassaemia treated with luspatercept.
    Br J Haematol. 2024;204:2505-2507.
    >> Share

  103. CHEN Y, Liu H, Wang C, Chen W, et al
    The histone demethylase JMJD1C regulates CPS1 expression and promotes the proliferation of paroxysmal nocturnal haemoglobinuria clones through cell metabolic reprogramming.
    Br J Haematol. 2024;204:2468-2479.
    >> Share

  104. DAVILA J, O'Brien SH, Mitchell WB, Manwani D, et al
    Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
    Br J Haematol. 2024;204:2184-2193.
    >> Share

    May 2024
  105. PHONGPAO K, Pholngam N, Chokchaichamnankit D, Nuamsee K, et al
    Proteomic profiling of circulating beta-thalassaemia/haemoglobin E extra-cellular vesicles reveals that association with immunoglobulin induces membrane vesiculation.
    Br J Haematol. 2024;204:2025-2039.
    >> Share

  106. CASABIANCA M, Gauthier A, Nader E, Cannas G, et al
    Red blood cell senescence and vascular function in patients with hereditary spherocytosis with and without splenectomy.
    Br J Haematol. 2024;204:e41-e44.
    >> Share

  107. HAGRY J, Monnet X, Mekontso-Dessap A, Chantalat C, et al
    Comprehensive assessment, pain and ventilatory management during acute complications of adult sickle cell disease: A clinical practice survey in French intensive care units.
    Br J Haematol. 2024;204:e37-e40.
    >> Share

  108. MANARA R, Brotto D, Barillari MR, Costa G, et al
    Hearing loss in beta-thalassaemia: An Italian multicentre case-control study.
    Br J Haematol. 2024;204:2016-2024.
    >> Share

  109. LIPTON JM
    Understanding complex disease-related mechanisms: Rational therapies for Diamond-Blackfan anaemia.
    Br J Haematol. 2024;204:1598-1599.
    >> Share

  110. TOMBUL Z, Bahaj W, Ozturk M, Patel B, et al
    Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2024;204:2121-2124.
    >> Share

  111. ROGER G, Denormandie P, Gobe T, Azzolina D, et al
    Left ventricular global longitudinal strain and acute myocardial injury in patients with sickle cell disease admitted to the intensive care unit for vaso-occlusive crisis.
    Br J Haematol. 2024;204:2007-2015.
    >> Share

  112. DUNCAN BB, Lotter JL, Superata J, Barranta ME, et al
    Treatment of refractory/relapsed Diamond-Blackfan anaemia with eltrombopag.
    Br J Haematol. 2024;204:2077-2085.
    >> Share

  113. BIANCHI C, Margot H, Fernandes H, Pasquet M, et al
    Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.
    Br J Haematol. 2024;204:1899-1907.
    >> Share

  114. UKONMAANAHO EM, Dell'Anna S, Hakonen A, Wartiovaara-Kautto U, et al
    Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.
    Br J Haematol. 2024;204:2040-2048.
    >> Share

  115. GIORGETTI A, Nyilima S, Stoffel NU, Moretti D, et al
    Stable iron ((58)Fe) isotopic measurements in Kenyan toddlers during 3 months of iron supplementation demonstrate that half of the iron absorbed is lost.
    Br J Haematol. 2024;204:2057-2065.
    >> Share

  116. MAEDA T, Matsuda A, Kanda J, Kawabata H, et al
    Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registry.
    Br J Haematol. 2024;204:2086-2096.
    >> Share

  117. NEYER PJ, Kabore B, Nakas CT, Diallo S, et al
    Increased erythroferrone levels in malarial anaemia.
    Br J Haematol. 2024;204:2066-2070.
    >> Share

    April 2024
  118. ARCANJO GS, Souza MB, Domingos IF, Pereira-Martins DA, et al
    BMP6 and VDR gene polymorphisms are associated with osteonecrosis in a sickle cell anaemia cohort.
    Br J Haematol. 2024;204:1507-1514.
    >> Share

  119. CHANG A, Wilson SR, Morris S, Wichlan D, et al
    Nocturnal hypoxaemia is common in adults with sickle cell anaemia.
    Br J Haematol. 2024;204:1495-1499.
    >> Share

  120. JACOBS JW, Sharma D, Stephens LD, Figueroa Villalba CA, et al
    Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
    Br J Haematol. 2024;204:1500-1506.
    >> Share

  121. KUNVARJEE B, Contreras Yametti GP, Blouin AG, Linder GE, et al
    Donor-specific antibody desensitization with daratumumab prior to haematopoietic cell transplant for sickle cell disease: A case report.
    Br J Haematol. 2024;204:1540-1544.
    >> Share

    March 2024
  122. EBEA-UGWUANYI PO, Vidyasagar S, Connor JR, Frazer DM, et al
    Oral iron therapy: Current concepts and future prospects for improving efficacy and outcomes.
    Br J Haematol. 2024;204:759-773.
    >> Share

  123. KULASEKARARAJ A, Cavenagh J, Dokal I, Foukaneli T, et al
    Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
    Br J Haematol. 2024;204:784-804.
    >> Share

  124. LEE GM, Batchvarova M, Delahunty M, Boateng L, et al
    Sickle red blood cells directly activate neutrophils.
    Br J Haematol. 2024;204:e28-e30.
    >> Share

  125. JONASSAINT CR, Parchuri E, O'Brien JA, Lalama CM, et al
    Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease.
    Br J Haematol. 2024;204:1029-1038.
    >> Share

  126. HANSEN DL, Maquet J, Lafaurie M, Moller S, et al
    Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France.
    Br J Haematol. 2024;204:1072-1081.
    >> Share

  127. EARLY ML, Raja M, Luo A, Solow M, et al
    Blood pressure thresholds for the diagnosis of hypertensive disorders of pregnancy in sickle cell disease.
    Br J Haematol. 2024;204:1039-1046.
    >> Share

  128. KISALI EP, Iversen PO, Makani J
    Low vitamin B(12) blood levels in sickle cell disease: Data from a large cohort study in Tanzania.
    Br J Haematol. 2024;204:1047-1053.
    >> Share

  129. STEINBERG-SHEMER O, Yacobovich J, Noy-Lotan S, Dgany O, et al
    Biallelic hypomorphic variants in CAD cause uridine-responsive macrocytic anaemia with elevated haemoglobin-A2.
    Br J Haematol. 2024;204:1067-1071.
    >> Share

  130. LIU H, Ding K, Zhang W, Xing L, et al
    A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
    Br J Haematol. 2024;204:1082-1085.
    >> Share

  131. MUNARETTO V, Corti P, Bertoni E, Tripodi SI, et al
    Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system.
    Br J Haematol. 2024;204:1061-1066.
    >> Share

    February 2024
  132. WARE RE, Quinn CT
    The bold promise of gene therapy for sickle cell disease.
    Br J Haematol. 2024;204:381-382.
    >> Share

  133. STEENSMA DP
    Revisiting the first reported case of aplastic anaemia.
    Br J Haematol. 2024;204:455-458.
    >> Share

  134. KATAGIRI T, Iwasaki H, Fujieda A, Kasashima S, et al
    A case of hepatitis-associated aplastic anaemia following living-donor liver transplantation for fulminant hepatitis showing loss of heterozygosity in the 6p chromosome in the affected liver.
    Br J Haematol. 2024;204:623-627.
    >> Share

  135. HUNT RC, Kimchi-Sarfaty C
    A synonymous variant is unmasked in thalassaemia.
    Br J Haematol. 2024;204:399-401.
    >> Share

  136. KHWAJA J, Japzon N, Gabriel M, Raju K, et al
    Cold agglutinin disease and cryoglobulinaemia: A frequent coexistence with clinical impact.
    Br J Haematol. 2024;204:e21-e24.
    >> Share

  137. EARLY ML, Luo A, Solow M, Matusiak K, et al
    Natural history of blood pressure in sickle cell disease pregnancy.
    Br J Haematol. 2024;204:658-667.
    >> Share

  138. CHAKRAVORTY S, Drasar E, Kaya B, Kesse-Adu R, et al
    UK Haemoglobin Disorders Peer Review: A Quality Standards-based review programme for sickle cell disease and thalassaemia.
    Br J Haematol. 2024;204:668-676.
    >> Share

  139. SISLER I, McClish DK, Villella A, Valrie C, et al
    Impact of community health workers on quality of life in adolescents and young adults with sickle cell disease: The SHIP-HU study.
    Br J Haematol. 2024;204:649-657.
    >> Share

  140. GORIVALE M, Sawant P, Kargutkar N, Hariharan P, et al
    When a synonymous mutation breaks the silence in a thalassaemia patient.
    Br J Haematol. 2024;204:677-682.
    >> Share

    January 2024
  141. OYARBIDE U, Crane GM, Corey SJ
    The metabolic basis of inherited neutropenias.
    Br J Haematol. 2024;204:45-55.
    >> Share

  142. PETERS C
    Haematopoietic stem cell transplantation in children with sickle cell disease: Still to do?
    Br J Haematol. 2024;204:22-23.
    >> Share

  143. DANIEL Y, Henthorn J
    Lessons learnt in the screening and diagnosis of haemoglobinopathies.
    Br J Haematol. 2024;204:68-73.
    >> Share

  144. SHOOK LM, Ware RE
    Screening for haemoglobin disorders: One size may not fit all.
    Br J Haematol. 2024;204:26-28.
    >> Share

  145. CSEH A, Galimard JE, de la Fuente J, Isgro A, et al
    Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.
    Br J Haematol. 2024;204:e1-e5.
    >> Share

  146. GUINDO A, Cisse Z, Keita I, Desmonde S, et al
    Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan(R) and HemotypeSC(R)) on cord blood.
    Br J Haematol. 2024;204:337-345.
    >> Share

  147. ALLALI S, Marquant F, Rignault-Bricard R, Taylor M, et al
    Oral famotidine reduces the plasma level of soluble P-selectin in children with sickle cell disease.
    Br J Haematol. 2024;204:346-351.
    >> Share

    December 2023
  148. PIZZO A, Porter JS, Carroll Y, Burcheri A, et al
    Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators.
    Br J Haematol. 2023;203:712-721.
    >> Share

  149. MISHKIN AD, Prince EJ, Leimbach EJ, Mapara MY, et al
    Psychiatric comorbidities in adults with sickle cell disease: A narrative review.
    Br J Haematol. 2023;203:747-759.
    >> Share

    November 2023
  150. GREEN NS, Rosano C, Bangirana P, Opoka R, et al
    Neurofilament light chain: A potential biomarker for cerebrovascular disease in children with sickle cell anaemia.
    Br J Haematol. 2023;203:460-467.
    >> Share

  151. BANDINI P, Borras N, Fernandez Mellid E, Martin-Fernandez L, et al
    First description of bone marrow failure syndrome in Spain caused by mutations in the ERCC6L2 gene.
    Br J Haematol. 2023;203:e102-e107.
    >> Share

  152. STEWART GW, Gibson JS, Rees DC
    The cation-leaky hereditary stomatocytosis syndromes: A tale of six proteins.
    Br J Haematol. 2023;203:509-522.
    >> Share

  153. NOVAK W, Berner J, Svaton M, Jimenez-Heredia R, et al
    Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
    Br J Haematol. 2023;203:678-683.
    >> Share

  154. SCULLY M, Rayment R, Clark A, Westwood JP, et al
    A British Society for Haematology Guideline: Diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies.
    Br J Haematol. 2023;203:546-563.
    >> Share

  155. FERMO E, Zaninoni A, Vercellati C, Marcello AP, et al
    When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms.
    Br J Haematol. 2023;203:684-687.
    >> Share

    October 2023
  156. ALADJIDI N, Pincez T, Rieux-Laucat F, Nugent D, et al
    Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
    Br J Haematol. 2023;203:28-35.
    >> Share

  157. RANQUE B, Diaw M, Dembele AK, Lapoumeroulie C, et al
    Association of haemolysis markers, blood viscosity and microcirculation function with organ damage in sickle cell disease in sub-Saharan Africa (the BIOCADRE study).
    Br J Haematol. 2023;203:319-326.
    >> Share

  158. ALSULTAN A, Abujoub R, Alsudairy R, Memon S, et al
    Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
    Br J Haematol. 2023;203:255-263.
    >> Share

  159. HEBBEL RP, Milbauer L, Wei P
    A novel promoter of endothelial dysfunction in African Americans: Relevance to sickle cell anaemia.
    Br J Haematol. 2023;203:e71-e73.
    >> Share

    September 2023
  160. ZHANG Y, Xie H, Liang G, Qin Y, et al
    A novel gain-of-function PIP4K2A mutation elevates the expression of beta-globin and aggravates the severity of alpha-thalassemia.
    Br J Haematol. 2023;202:1018-1023.
    >> Share

  161. NANNELLI C, Bosman A, Cunningham J, Dugue PA, et al
    Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification.
    Br J Haematol. 2023;202:1024-1032.
    >> Share

  162. DE ALCANTARA PEDRO PP, Castro CHM, Pinheiro MM, Goncalves LM, et al
    Vertebral fractures and low lean mass in young men with sickle cell disease: Lack of association with bone mineral density and clinical characteristics.
    Br J Haematol. 2023;202:e46-e49.
    >> Share

  163. HAN J, Saraf SL, Gordeuk VR
    Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
    Br J Haematol. 2023;202:916-918.
    >> Share

  164. ESPERTI S, Nader E, Boisson C, Carin R, et al
    Mitochondria retention in mature RBCs from haemoglobin SC patients.
    Br J Haematol. 2023;202:e36-e38.
    >> Share

  165. KNIGHT-MADDEN J, King L, Asnani M, Skyers N, et al
    Needs assessment in adults and parents of children living with sickle cell disease in Jamaica.
    Br J Haematol. 2023;202:e31-e35.
    >> Share

  166. NAKAHARA H, Cheedarla N, Verkerke HP, Cheedarla S, et al
    Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.
    Br J Haematol. 2023;202:937-941.
    >> Share

  167. GUPTA A, Gooda R, Marouf R
    Pseudo-Gaucher cells in a splenectomised Beta-Thalassemia patient.
    Br J Haematol. 2023;202:911.
    >> Share

  168. ZOLLER H, Wagner S, Schaefer B
    What is wrong in doing good?
    Br J Haematol. 2023;202:1089-1090.
    >> Share

  169. ASHER S, Shah R, Ings S, Horder J, et al
    Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
    Br J Haematol. 2023;202:1224-1227.
    >> Share

  170. DASARI S, Tse W, Wang J
    Real-world evidence of incidence and outcomes of aplastic anaemia following administration of immune checkpoint inhibitors.
    Br J Haematol. 2023;202:1205-1208.
    >> Share

  171. CHU Z, Cushway T, Wong M, Lim KX, et al
    Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore.
    Br J Haematol. 2023;202:1199-1204.
    >> Share

  172. MANGANAS K, Delicou S, Xydaki A, Kourakli A, et al
    Predisposing factors for advanced liver fibrosis in patients with sickle cell disease.
    Br J Haematol. 2023;202:1192-1198.
    >> Share

  173. JACOBS JW, Ding JJ, Tormey CA, Abels EA, et al
    Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newborn.
    Br J Haematol. 2023;202:1213-1215.
    >> Share

    August 2023
  174. ELSHERIF L, Kanthakumar P, Afolabi J, Stratton AF, et al
    Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemia.
    Br J Haematol. 2023;202:669-673.
    >> Share

  175. GIBSON JS, Stewart GW
    A critical role for altered red cell cation permeability in pathogenesis of sickle cell disease and other haemolytic anaemias.
    Br J Haematol. 2023;202:462-464.
    >> Share

  176. NADER E, Conran N, Leonardo FC, Hatem A, et al
    Piezo1 activation augments sickling propensity and the adhesive properties of sickle red blood cells in a calcium-dependent manner.
    Br J Haematol. 2023;202:657-668.
    >> Share

  177. HAMANI S, Lioure B, Nicolae A, Lipsker D, et al
    A Rare Cause of Refractory Anaemia hidden between Folds.
    Br J Haematol. 2023;202:712.
    >> Share

  178. JOLY P, Nader E, Ketels F, Boisson C, et al
    Effects of pyruvate kinase activators on red blood cell properties in sickle cell disease.
    Br J Haematol. 2023;202:e27-e30.
    >> Share

  179. ZHANG X, Han J, Shah BN, Saraf SL, et al
    Platelet count decline and high neutrophil count within the first day of admission for painful sickle cell vaso-occlusive episodes predict severe complications.
    Br J Haematol. 2023;202:e20-e23.
    >> Share

  180. MARTIN OY, Margulies S, Speller-Brown B, Majumdar S, et al
    The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
    Br J Haematol. 2023;202:479-484.
    >> Share

    July 2023
  181. RAI MP, Lee EJ, Bussel JB
    Maintenence rituximab following induction in autoimmune cytopenias.
    Br J Haematol. 2023;202:153-158.
    >> Share

  182. HAROUN E, Dutta D, Lim SH
    Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell disease.
    Br J Haematol. 2023;202:184-194.
    >> Share

  183. FERRONE FA
    More of the same? Voxelotor spawns a successor, but on what success does it build?
    Br J Haematol. 2023;202:13-15.
    >> Share

  184. DUFU K, Alt C, Strutt S, Partridge J, et al
    GBT021601 improves red blood cell health and the pathophysiology of sickle cell disease in a murine model.
    Br J Haematol. 2023;202:173-183.
    >> Share

    June 2023
  185. SHETH S, Taher AT, Coates TD, Kattamis A, et al
    Management of luspatercept therapy in patients with transfusion-dependent beta-thalassaemia.
    Br J Haematol. 2023;201:824-831.
    >> Share

  186. WU J, Wang J, Tang N, Wang X, et al
    An atypical patient with bone marrow failure syndrome-2 without microcephaly and learning disability in a Chinese family.
    Br J Haematol. 2023;201:e50-e53.
    >> Share

  187. LIN Y, Del Giudice ME, Kron A, Meirovich H, et al
    A pilot feasibility trial of daily versus every other day oral iron supplementation in patients with iron deficiency anaemia.
    Br J Haematol. 2023;201:1000-1004.
    >> Share

  188. PENG Y, Liang L, Zhang H, Liu H, et al
    Single-cell profiling of ineffective erythropoiesis in a mouse model of beta-thalassaemia intermedia.
    Br J Haematol. 2023;201:982-994.
    >> Share

  189. BAIN BJ, Daniel Y, Henthorn J, de la Salle B, et al
    Significant haemoglobinopathies: A guideline for screening and diagnosis: A British Society for Haematology Guideline: A British Society for Haematology Guideline.
    Br J Haematol. 2023;201:1047-1065.
    >> Share

  190. JACOBS JW, Stephens LD, Allen ES, Binns TC, et al
    Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review.
    Br J Haematol. 2023;201:1025-1032.
    >> Share

  191. GENDREAU S, Cecchini J, Perier F, Razazi K, et al
    Effect of high-flow oxygen therapy on regional oxygen saturation during vaso-occlusive pain crisis: An observational study.
    Br J Haematol. 2023;201:e58-e61.
    >> Share

  192. TAKASAKI K, Friedman DF, Uter S, Vege S, et al
    Variant RHD alleles and Rh immunization in patients with sickle cell disease.
    Br J Haematol. 2023;201:1220-1228.
    >> Share

  193. LI J, Wang Y, Zhang Y, Zhang X, et al
    Haematopoietic stem cell transplantation for hepatitis-associated aplastic anaemia and non-hepatitis-associated aplastic anaemia: A propensity score-matched analysis.
    Br J Haematol. 2023;201:1179-1191.
    >> Share

  194. CHEMINET G, Brunetti A, Khimoud D, Ranque B, et al
    Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission.
    Br J Haematol. 2023;201:1229-1238.
    >> Share

  195. JARISCH A, Salzmann-Manrique E, Soerensen J, Sach G, et al
    Donor-type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors.
    Br J Haematol. 2023;201:1159-1168.
    >> Share

    May 2023
  196. GAVILLET M, Rufer N, Grandoni F, Rizzi M, et al
    Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
    Br J Haematol. 2023;201:581-584.
    >> Share

  197. PICCIN A, Magzoub I, Hervig T
    The 'scintilla' starting vaso-occlusion in sickle cell disease.
    Br J Haematol. 2023;201:379-380.
    >> Share

  198. AN R, Man Y, Cheng K, Zhang T, et al
    Sickle red blood cell-derived extracellular vesicles activate endothelial cells and enhance sickle red cell adhesion mediated by von Willebrand factor.
    Br J Haematol. 2023;201:552-563.
    >> Share

  199. TOWERMAN AS, Guilliams KP, Guerriero R, Shinawi MS, et al
    Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease.
    Br J Haematol. 2023;201:e30-e33.
    >> Share

  200. LUNATI-ROZIE A, Janin A, Faubert E, Nony S, et al
    Use of minigene assays as a useful tool to confirm the pathogenic role of intronic variations of the ANK1 gene: Report of two cases of hereditary spherocytosis.
    Br J Haematol. 2023;201:e46-e49.
    >> Share

  201. TENNENBAUM J, Volle G, Pouchot J, Joseph L, et al
    Increased risk of venous thromboembolism in splenectomized patients with sickle cell disease.
    Br J Haematol. 2023;201:793-796.
    >> Share

    April 2023
  202. SICA M, Barone F, Nannelli C, Ricci P, et al
    The long-acting anti-C5 ravulizumab results in C3 binding to PNH red cells similar to its parental molecule eculizumab.
    Br J Haematol. 2023;201:e1-e4.
    >> Share

  203. KAPUR R
    The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
    Br J Haematol. 2023;201:13-14.
    >> Share

  204. ROSSI M, Pirenne F, Le Roux E, Smaine D, et al
    Delayed haemolytic transfusion reaction in paediatric patients with sickle cell disease: A retrospective study in a French national reference centre.
    Br J Haematol. 2023;201:125-132.
    >> Share

  205. WANG YM, Loveless M, Miller E, Nelson AS, et al
    Phenotypes of adults with Fanconi anaemia.
    Br J Haematol. 2023;201:133-139.
    >> Share

  206. RABELO IB, Chiba AK, Moritz E, D'Amora P, et al
    Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
    Br J Haematol. 2023;201:140-149.
    >> Share

  207. JACOB M, Kawadler JM, Murdoch R, Ahmed M, et al
    Brain volume in Tanzanian children with sickle cell anaemia: A neuroimaging study.
    Br J Haematol. 2023;201:114-124.
    >> Share

  208. KOREN A
    The continuing global challenges of treating patients with beta-thalassemia.
    Br J Haematol. 2023;201:183-184.
    >> Share

  209. JACOBS JW, Binns TC, Abels E, Tormey CA, et al
    Autoimmune haemolytic anaemia secondary to babesiosis: A review of reported cases and description of a novel association with cold antibody-mediated haemolytic anaemia.
    Br J Haematol. 2023;201:364-369.
    >> Share

  210. SUTRA DEL GALY A, Willems L, D'Aveni M, Pautas C, et al
    Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
    Br J Haematol. 2023;201:e16-e20.
    >> Share

  211. HOKLAND P, Daar S, Khair W, Sheth S, et al
    Thalassaemia-A global view.
    Br J Haematol. 2023;201:199-214.
    >> Share

  212. DONZE C, Benoit A, Thuret I, Faust C, et al
    beta-Thalassemia in childhood: Current state of health in a high-income country.
    Br J Haematol. 2023;201:334-342.
    >> Share

  213. EARLEY EJ, Kelly S, Fang F, Alencar CS, et al
    Genome-wide association study of early ischaemic stroke risk in Brazilian individuals with sickle cell disease implicates ADAMTS2 and CDK18 and uncovers novel loci.
    Br J Haematol. 2023;201:343-352.
    >> Share

  214. JACOBS JW, Booth GS, Guarente J, Schlafer D, et al
    Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
    Br J Haematol. 2023;201:227-233.
    >> Share

    March 2023
  215. TSITSIKAS DA, Rowe S, Bosch A, Hui C, et al
    Addition of plasma exchange to red cell exchange improves outcomes of fat embolism syndrome in sickle cell disease.
    Br J Haematol. 2023;200:e50-e52.
    >> Share

  216. MCKEAGUE S, Peake N, Lovelock D, Chow J, et al
    Acquired HbH disease diagnosed by HbA1c capillary electrophoresis.
    Br J Haematol. 2023;200:687.
    >> Share

  217. KOEHL B, Claude L, Reminy K, Tarer V, et al
    Erythrocyte type 1 equilibrative nucleoside transporter expression in sickle cell disease and sickle cell trait.
    Br J Haematol. 2023;200:812-820.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016